University of Massachusetts
Also known as: Baystate Medical Center | Baystate Medical Center-Children's Hospital | Baystate Medical Center, Springfield, MA | Center for Advancing Point of Care Technologies | David Cochran | Division of Hematology and Oncology, University of Massachusetts Medical School | Eman Nada | Feiran Lou | Gianna Wilkie | Gyongyi Szabo | Jeffrey Rade | J. Matthias Walz | Jonathan Gerber | Massachusetts Department of Health | Massachusetts Host-Microbiome Center | Massbiologics of University of Massachusetts Medical School | Mind and Life Institute, Hadley, Massachusetts | Riley McLean | The University of Massachusetts Medical School | UMass Chan Medical School | UMass Chan Medical School; UMass Memorial Medical Center; Meyers Health Care Institute | UMass Medical School | UMASS Medical School | UMass Memorial Healthcare | UMass Memorial Health Care | UMass Memorial Medical Center | UMass Worcester | University of MA Medical School (UMMS)-II Biotech | University of Massachusetts, Amherst | University of Massachusetts at Boston | University of Massachusetts, Boston | University of Massachusetts Chan Medical School | University of Massachusetts Chan Medical School, Worcester | University of Massachusetts, Lowell | University of MassachusettsMedical School | University of Massachusetts Medical School, Worcester, MA | University of Massachusetts Memorial Healthcare | University of Massachusetts/UMass Memorial | University of Massachusetts, Worcester | Unversity of Massachusetts Medical School | Xiaoduo Fan
Highest phase reached
Phase 4
First clinical trial
Apr 1, 1983Last known activity
Oct 29, 2025
Timeline
1860s
- Jan 1, 1863
University of Massachusetts— Founded
Drugs by trial phase (182 distinct, 152 trials)
Phase 4 (39 own, 0 via acquisition)
Phase 3 (42 own, 0 via acquisition)
Phase 2 (52 own, 0 via acquisition)
Phase 1 (25 own, 0 via acquisition)
Other trials (24 own, 0 via acquisition)
Indications
Studied for
- Acquired Immunodeficiency Syndrome
- Acute Coronary Syndrome
- Acute Lung Injury
- Alcoholism
- alpha 1-Antitrypsin Deficiency
- Altitude Sickness
- Alzheimer Disease
- Amyotrophic Lateral Sclerosis
- Ankle Fractures
- Appendiceal Neoplasms
- Arterial Occlusive Diseases
- Arteriosclerosis
- Arteriovenous Malformations
- Arthritis
- Arthritis, Rheumatoid
- Atrophy
- Autism Spectrum Disorder
- Autistic Disorder
- Bipolar Disorder
- Blindness
- Bronchopulmonary Dysplasia
- Carcinoma
- Carcinoma, Small Cell
- Cardiovascular Diseases
- Cerebral Hemorrhage
- Child Development Disorders, Pervasive
- Clostridium Infections
- Communicable Diseases
- Congenital Abnormalities
- Coronary Artery Disease
- Coronary Disease
- Cystic Fibrosis
- Cytomegalovirus Retinitis
- Depression
- Depressive Disorder
- Diabetes, Gestational
- Diabetes Mellitus
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Disease
- Edema
- Embolism
- Fatty Liver
- Fatty Liver, Alcoholic
- Fibrosis
- Fistula
- Fractures, Bone
- Fragile X Syndrome
- Gastrointestinal Hemorrhage
- Glioblastoma
- Glucose Intolerance
- Graves Disease
- Gynecomastia
- Heart Diseases
- Heart Failure
- Hemangioma
- Hemorrhage
- Hepatitis
- Hepatitis A
- Hepatitis, Alcoholic
- Hepatitis C
- Hepatitis C, Chronic
- Hernia
- Hip Fractures
- HIV Infections
- HIV Seropositivity
- Hypertension, Pulmonary
- Hyperthyroidism
- Hypoxia
- Infarction
- Infections
- Inflammation
- Insulin Resistance
- Intermittent Claudication
- Ischemia
- Labor Pain
- Leber Congenital Amaurosis
- Leukemia
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Leukemia, Myeloid
- Liver Cirrhosis
- Liver Diseases
- Lung Diseases
- Lung Neoplasms
- Lupus Erythematosus, Systemic
- Lymphoma
- Lymphoma, B-Cell
- Lymphoma, Non-Hodgkin
- Major Depressive Disorder
- Malaria
- Marijuana Abuse
- Melanoma
- Meningococcal Infections
- Mental Disorders
- Metabolic Syndrome
- Mood Disorders
- Motor Neuron Disease
- Multiple Myeloma
- Multiple Sclerosis
- Multiple Sclerosis, Relapsing-Remitting
Recent trials (50)
- NCT04445207Lead sponsorN/A—
- NCT05317780CollaboratorN/A—
- NCT04445207Sponsor investigatorN/A—
- NCT07170462Lead sponsorEarly Phase 1Oct 29, 2025
- NCT07170462Sponsor investigatorEarly Phase 1Oct 29, 2025
- NCT07170462OfficialEarly Phase 1Oct 29, 2025
- NCT06876038Sponsor investigatorPhase 2May 31, 2025
- NCT06876038Lead sponsorPhase 2May 31, 2025
- NCT06896136Lead sponsorPhase 1Feb 11, 2025
- NCT06896136OfficialPhase 1Feb 11, 2025
- NCT06896136Sponsor investigatorPhase 1Feb 11, 2025
- NCT06226129OfficialPhase 4Feb 14, 2024
- NCT06226129Lead sponsorPhase 4Feb 14, 2024
- NCT06101745CollaboratorPhase 2/Phase 3Jan 31, 2024
- NCT06624176Sponsor investigatorN/AJan 10, 2024
Details
- Founded
- Amherst, MA, US Jan 1, 1863
- Last known activity
- Oct 29, 2025